Artiva Biotherapeutics, Inc. ARTV EBITDA

EBITDA at other companies

Bristol-Myers SquibbBMY

$4.68B+68.1%

Gilead SciencesGILD

-$10.3B-501%

Kyverna Therapeutics, Inc.KYTX

-$41.02M+12.6%

Immix Biopharma, Inc.IMMX

-$10.71M-131%

ImmunityBio, Inc.IBRX

-$65.41M-7.9%

Cullinan Therapeutics, Inc.CGEM

-$57.18M+24.5%

FAQ

What is Artiva Biotherapeutics, Inc.'s EBITDA?

Artiva Biotherapeutics, Inc. (ARTV) reported EBITDA of -$26.2M in Q2 2026.

How has Artiva Biotherapeutics, Inc.'s EBITDA changed year-over-year?

Artiva Biotherapeutics, Inc.'s EBITDA decreased by 18.2% year-over-year, from -$22.17M to -$26.2M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.